These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14910643)

  • 21. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
    Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
    J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on synthetic antimalarial drugs; the effect of therapeutic courses of paludrine on the relapse-rate of vivax malaria.
    ANDREWS WH; GALL D; MAEGRAITH BG
    Ann Trop Med Parasitol; 1947 Dec; 41(3-4):375-9. PubMed ID: 18902136
    [No Abstract]   [Full Text] [Related]  

  • 23. The potentiation of the antimalarial activity of chloroguanide by p-aminobenzoic acid competitors.
    GREENBERG J
    J Pharmacol Exp Ther; 1949 Oct; 97(2):238-42. PubMed ID: 15391935
    [No Abstract]   [Full Text] [Related]  

  • 24. Metachloridine-substituted aryl biguanides as possible antimalarial compounds.
    BAMI HL; IYER BH; GUHA PC
    Nature; 1948 Jul; 162(4108):146. PubMed ID: 18939062
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of paludrine and other antimalarials.
    WILLIAMSON J; BERTRAM DS; LOURIE EM
    Nature; 1947 Jun; 159(4052):885. PubMed ID: 20252560
    [No Abstract]   [Full Text] [Related]  

  • 26. The pharmacology of paludrine and some other new antimalarials.
    SPINKS A; TOTTEY MM; MAEGRAITH BG
    Biochem J; 1946; 40(1):i. PubMed ID: 21027565
    [No Abstract]   [Full Text] [Related]  

  • 27. Formation of the diuretic chlorazanil from the antimalarial drug proguanil--implications for sports drug testing.
    Thevis M; Geyer H; Thomas A; Tretzel L; Bailloux I; Buisson C; Lasne F; Schaefer MS; Kienbaum P; Mueller-Stoever I; Schänzer W
    J Pharm Biomed Anal; 2015 Nov; 115():208-13. PubMed ID: 26226108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man.
    Edstein MD; Veenendaal JR; Scott HV; Rieckmann KH
    Chemotherapy; 1988; 34(5):385-92. PubMed ID: 3180907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphic oxidative metabolism of proguanil in a Nigerian population.
    Bolaji OO; Sadare IO; Babalola CP; Ogunbona FA
    Eur J Clin Pharmacol; 2002 Nov; 58(8):543-5. PubMed ID: 12451432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A statistical analysis of the antimalarial activity of proguanil and cycloguanil in human volunteers.
    Yeo AE; Edstein MD; Shanks GD; Rieckmann KH
    Ann Trop Med Parasitol; 1994 Dec; 88(6):587-94. PubMed ID: 7893172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. THE ANTIMALARIAL ACTIVITY OF CI-501 (CAMOLAR) AGAINST FALCIPARUM MALARIA.
    CONTACOS PG; COATNEY GR; LUNN JS; KILPATRICK JW
    Am J Trop Med Hyg; 1964 May; 13():386-90. PubMed ID: 14159974
    [No Abstract]   [Full Text] [Related]  

  • 32. Experiments with antimalarial drugs in man. IV. An experiment to investigate the prophylactic value of proguanil against a strain of Plasmodium falciparum known to be resistant to therapeutic treatment.
    DAVEY DG; ROBERTSON GI
    Trans R Soc Trop Med Hyg; 1957 Sep; 51(5):463-6. PubMed ID: 13468008
    [No Abstract]   [Full Text] [Related]  

  • 33. Correlation between proguanil and metabolites in plasma and saliva.
    Alexander C; Nathwani D; Zimbler N; Taylor RB
    J Antimicrob Chemother; 1995 Dec; 36(6):1113-5. PubMed ID: 8821621
    [No Abstract]   [Full Text] [Related]  

  • 34. FURTHER OBSERVATIONS ON THE ANTIMALARIAL ACTIVITY OF CI-501 (CAMOLAR) AGAINST THE CHESSON STRAIN OF VIVAX MALARIA.
    COATNEY GR; CONTACOS PG; LUNN JS
    Am J Trop Med Hyg; 1964 May; 13():383-5. PubMed ID: 14159973
    [No Abstract]   [Full Text] [Related]  

  • 35. LABORATORY STUDIES ON THE REPOSITORY ANTIMALARIAL ACTIVITY OF 4,4'-DIACETYLAMINODIPHENYLSULFONE, ALONE AND MIXED WITH CYCLOGUANIL PAMOATE (CI-501).
    THOMPSON PE; OLSZEWSKI B; WAITZ JA
    Am J Trop Med Hyg; 1965 May; 14():343-53. PubMed ID: 14292737
    [No Abstract]   [Full Text] [Related]  

  • 36. High frequencies of CYP2C19 mutations and poor metabolism of proguanil in Vanuatu.
    Kaneko A; Kaneko O; Taleo G; Björkman A; Kobayakawa T
    Lancet; 1997 Mar; 349(9056):921-2. PubMed ID: 9093256
    [No Abstract]   [Full Text] [Related]  

  • 37. Paludrine, a new anti-malarial drug.
    CHOUDHURY M
    Antiseptic; 1947 Sep; 44(9):606-8. PubMed ID: 18897458
    [No Abstract]   [Full Text] [Related]  

  • 38. The inhibitory action of some antimalarial drugs and related compounds on the hexokinase of yeast and of Plasmodium berghei.
    FRASER DM; KERMACK WO
    Br J Pharmacol Chemother; 1957 Mar; 12(1):16-23. PubMed ID: 13413145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in antimalarial prescriptions in Australia 2002 to 2005.
    Leggat PA
    J Travel Med; 2008; 15(5):302-6. PubMed ID: 19006502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modern antimalarial therapy.
    PFEIFFER CC
    Mod Hosp; 1952 Aug; 79(2):106-8. PubMed ID: 12992919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.